Potential Therapeutic Response In Urogenital Tumors
Condition(s):Urogenital Neoplasms; Drug TherapyLast Updated:July 8, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Urogenital Neoplasms; Drug TherapyLast Updated:July 8, 2022Completed
Condition(s):NK Cell Mediated Immunity; NK Cell Cytokine Production; Kidney CancerLast Updated:September 21, 2021Completed
Condition(s):Genitourinary Neoplasms; Neoplasms, GenitourinaryLast Updated:July 24, 2023Recruiting
Condition(s):Covid19; Genito Urinary CancerLast Updated:September 22, 2021Unknown status
Condition(s):Gastric CancerLast Updated:May 20, 2019Completed
Condition(s):Wilms’ Tumor; AniridiaLast Updated:January 27, 2020Unknown status
Condition(s):Urothelial Cancer; Bladder Cancer; Genitourinary Cancer; Urogenital Neoplasms; Urogenital CancerLast Updated:March 6, 2024Recruiting
Condition(s):Genitourinary Cancer; Adrenocortical Carcinoma; Non-urothelial Bladder; Non-urothelial Upper Tract; Penile Cancer; Non-adenocarcinoma Prostate Cancer; Refractory Germ-cell; High Grade Neuroendocrine Carcinoma/Small Cell CarcinomaLast Updated:February 6, 2024Active, not recruiting
Condition(s):Bladder Cancer; Renal CancerLast Updated:January 14, 2022Unknown status
Condition(s):Microbial DiseaseLast Updated:January 30, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.